Scinovex
articleTop 1% cited

Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)

British Journal of Dermatology · 2007 · Vol. 157(5) · pp. 989–996
Alexis SidoroffAriane DunantCécile ViboudSima HalevyJan Nico Bouwes BavinckLuigi NaldiM MockenhauptJ.P. FagotJ Roujeau

Abstract

Medications associated with AGEP differ from those associated with Stevens-Johnson syndrome or toxic epidermal necrolysis. Different timing patterns from drug intake to reaction onset were observed for different drugs. Infections, although possible triggers, played no prominent role in causing AGEP and there was no evidence that AGEP is a variant of pustular psoriasis.

Drug-Induced Adverse ReactionsContact Dermatitis and AllergiesAutoimmune Bullous Skin DiseasesVenereologyMedicineAcute generalized exanthematous pustulosisMultinational corporationLibrary scienceDermatologyPolitical scienceLaw

MeSH terms

TerbinafineAnti-Infective AgentsAustriaCalcium Channel BlockersDrug EruptionsDiltiazemExanthemaFemaleFranceHumansHydroxychloroquineIsraelItalyMaleMiddle Aged
Citations
555
FWCI
15.51
field-weighted impact
References
65
Percentile
99%
vs. same field & year
Citations per year
References
GENERALIZED PUSTULAR PSORIASIS.
British Journal of Dermatology · 1968 · 534 citations
Acute generalized exanthematous pustulosis. Analysis of 63 cases
Archives of Dermatology · 1991 · 523 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR) · Scinovex